According to the research report, the global neuromodulation market was valued at USD 5.61 billion and is expected to reach USD 14.57 billion by 2030, to grow at a CAGR of 11.9% during the forecast period. Market Growth Drivers Rising Prevalence of Neurological Disorders: Conditions such as Parkinson’s disease, chronic pain, epilepsy, and major depressive disorder are...